- Moneycontrol /
- Market /
- Share/Stock Price /
- Pharmaceuticals /
- ANNOUNCEMENT
BSE Live
Jul 03, 16:00Prev. Close
1467.15
Open Price
1470.00
Bid Price (Qty.)
1466.50 (1)
Offer Price (Qty.)
1474.00 (1)
NSE Live
Jul 03, 15:57Prev. Close
1466.25
Open Price
1479.85
Bid Price (Qty.)
1466.10 (1)
Offer Price (Qty.)
0.00 (0)
GLAXOSMITHKLINE PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2020 ,inter alia, to consider and approve Un- Audited Financial Results for the first quarter ended 30th June 2020
GlaxoSmithKline Pharmaceuticals - Closure of Trading Window
We wish to inform you that the in terms of the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015, the trading period for buying or selling of Company's shares is closed from Wednesday, 1st July, 2020 and shall reopen on Monday, 3rd August, 2020 i.e. after the approval and declaration of Un-audited financial results for the first quarter ended 30th June, 2020 by the Board of Directors at its meeting scheduled to be held on 29th July, 2020.
GlaxoSmithKline Pharmaceuticals - Reg. 34 (1) Annual Report
Pursuant to clause 34 of the Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015, we are submitting the soft copy of AGM Notice & Annual Report for year ended 31st March, 2020 of the Company.
GlaxoSmithKline Pharmaceuticals - Announcement under Regulation 30 (LODR)-Newspaper Publication
Advt relating Notice of Annual General Meeting
GlaxoSmithKline Pharmaceuticals - Announcement under Regulation 30 (LODR)-Newspaper Publication
Intimation to Shareholder(s) - Notice for registration of email ids of shareholders
GlaxoSmithKline Pharmaceuticals - Intimation Of Record Date Pursuant To Regulation 42 Of The Securities & Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.
This is further to our letter dated 18th May 2020 wherein we had declared the Annual Results and Dividend for the financial year ended 31st March, 2020.
GlaxoSmithKline Pharmaceuticals - Corporate Action-Board to consider Dividend
Intimation of Record Date pursuant to Regulation 42 of the Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
GlaxoSmithKline Pharmaceuticals Limited
GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure of material impact of COVID 19 pandemic '.
GlaxoSmithKline Pharmaceuticals - Disclosure Of Material Impact Of COVID 19 Pandemic
Disclosure of material impact of COVID 19 pandemic
GlaxoSmithKline Pharmaceuticals Limited
GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about disclosure on Related Party Transactions
Announcement under Regulation 30 (LODR)
| Jul 4, 11:49
Closure Of Registers Of Members And Share Transfer Books For The Purpose Of An...
| Jul 4, 11:47
Submission Of Outcome Of Board Meeting Held On 4Th July, 2020.
| Jul 4, 11:44
Results
| Jul 4, 11:42
Statement Of Investor Complaints For The Quarter Ended June 2020
| Jul 4, 11:41
Closure of Trading Window
| Jul 4, 11:40
Reply To The Clarification Sought By BSE Limited Ref: L/SURV/ONL/PV/GS...
| Jul 4, 11:39
Statement Of Investor Complaints For The Quarter Ended June 2020...
| Jul 4, 11:35
Compliances
| Jul 4, 11:33
Reg. 34 (1) Annual Report
| Jul 4, 11:30
Statement Of Investor Complaints For The Quarter Ended June 2020
| Jul 4, 11:22
Board Meeting Intimation for Consideration Of Financial Results
| Jul 4, 11:22
Quarterly Disclosures By Listed Entities Of Defaults On Payment Of Interest/...
| Jul 4, 11:21
Closure of Trading Window
| Jul 4, 11:19
38Th Annual General Meeting Notice On July,30 2020
| Jul 4, 11:16
Statement Of Investor Complaints For The Quarter Ended June 2020
| Jul 4, 11:16
Announcement under Regulation 30 (LODR)
| Jul 4, 11:14
Reg. 34 (1) Annual Report
| Jul 4, 11:13
Shareholding for the Period Ended June 30, 2020
| Jul 4, 11:12
Compliances
| Jul 4, 11:12
| Meeting Date : | Jul 29, 2020 |
| Remark : | Quarterly Results |
